Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil

Abstract

Objective: To describe the effects of the anti-tumor necrosis factor neutralizing antibody, infliximab, and the antiproliferative immunosuppressant, mycophenolate mofetil, in refractory neurosarcoidosis.